- Home
- / Celon Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Celon Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
ZŁ244.3 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| PLN | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 125.2M | 102.2M | 139.3M | 199.1M | 194.6M | 216.6M | 207.2M | 244.3M |
| Cost of goods sold | 46.5M | 39.2M | 43.0M | 99.1M | 116.1M | 113.2M | 105.2M | 119.3M |
| Gross profit | 83.9M | 68.2M | 110.3M | 100.0M | 79.0M | 103.6M | 118.8M | 126.6M |
| Gross profit margin, % | 66.7% | 79.2% | 50.2% | 40.6% | 47.8% | 57.3% | 51.8% | |
| Operating expense total | 30.5M | 41.3M | 42.1M | 69.3M | 72.8M | 82.0M | 102.9M | 102.9M |
| Depreciation and amortization | 17.2M | 20.6M | 30.9M | 41.3M | 44.1M | 50.0M | 51.9M | 48.5M |
| EBITDA | 53.4M | 26.8M | 68.2M | 30.8M | 6.2M | 21.7M | 10.4M | (10.4M) |
| EBITDA margin, % | 26.3% | 49.0% | 15.4% | 3.2% | 10.0% | 5.0% | -4.2% | |
| EBIT | 35.3M | 6.2M | 37.3M | (10.6M) | (37.9M) | (28.4M) | (41.5M) | (58.9M) |
| EBIT margin, % | 6.1% | 26.8% | -5.3% | -19.5% | -13.1% | -20.0% | -24.1% | |
| Interest income | 3.4M | 1.8M | 142.0K | 84.0K | 1.8M | 372.0K | 157.0K | 503.0K |
| Interest expense | 1.1M | 926.0K | 1.3M | 1.6M | 1.7M | 2.7M | 2.5M | 1.6M |
| Pre tax profit | 37.5M | 7.8M | 22.1M | (15.1M) | (36.4M) | (20.0M) | (39.4M) | (59.0M) |
| Income tax expense | 7.8M | (4.1M) | 574.0K | (3.5M) | 2.8M | 8.2M | (4.9M) | 20.4M |
| Net Income | 29.7M | 11.9M | 21.5M | (11.6M) | (39.3M) | (28.1M) | (34.4M) | (79.4M) |